Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
278
-
Total 13F shares, excl. options
-
37.1M
-
Shares change
-
-495K
-
Total reported value, excl. options
-
$4.18B
-
Value change
-
-$54.3M
-
Number of buys
-
130
-
Number of sells
-
-113
-
Price
-
$112.77
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q2 2016
293 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q2 2016.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 278 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.1M shares
of 152M outstanding shares and own 24.33% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.75M shares), Select Equity Group, L.P. (2.29M shares), BROWN CAPITAL MANAGEMENT LLC (2.26M shares), BlackRock Fund Advisors (1.82M shares), Jackson Square Partners, LLC (1.69M shares), BAMCO INC /NY/ (1.64M shares), Neuberger Berman Group LLC (1.54M shares), Mairs & Power INC (1.35M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.24M shares), and BlackRock Institutional Trust Company, N.A. (1.16M shares).
This table shows the top 278 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.